3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasms
9
Carcinoma, Non-Small-Cell Lung
9
Carcinoma, Renal Cell
4
Carcinoma, Hepatocellular
4
Breast Neoplasms
3
Stomach Neoplasms
2
Solid Tumors
2
Mesothelioma, Malignant
2
Melanoma
2
Carcinoma
2
Adult Solid Neoplasm
2
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solitary Fibrous Tumor, Pleural
1
Solid Neoplasm
1
Seminoma
1
Sarcoma, Clear Cell
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Renal Insufficiency
1
Prostatic Neoplasms
1
Paraproteinemias
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteolysis
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Malignant Solid Tumour
1
Liver Neoplasms
1
Hypercalcemia
1
Interventions
Sorafenib
61
Bevacizumab
42
Oxaliplatin
24
Doxorubicin
22
Radiosurgery
20
Gemcitabine
20
Fluorouracil
20
Nivolumab
19
durvalumab
18
Radiofrequency Ablation
18
pembrolizumab
17
Capecitabine
17
lenvatinib
16
Cisplatin
16
atezolizumab
13
Leucovorin
13
Radiotherapy
11
tremelimumab
10
Cyclophosphamide
10
Carboplatin
10
Irinotecan
9
Ipilimumab
9
Drug Therapy
9
Everolimus
8
Cryosurgery
8
toripalimab
7
fludarabine
7
Sunitinib
7
Chemotherapy, Adjuvant
7
Melphalan
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Liver Neoplasms
×
ARQ 197
×
Clear all
NCT02029157
2017-10-09
JET-HCC
Kyowa Kirin Co., Ltd.
Phase 3
Completed
386 enrolled